Abstract
Objective: This study aimed to obtain an optimal and validated method of analyzing 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG) simultaneously in dried blood spot samples using ultra high-performance liquid chromatography-tandem mass spectrometry. Method: Separation was performed with a 1.7-µm amide column, which had a mobile phase with a flow rate of 0.2 mL/min and comprised 0.2% formic acid in water, 0.1% formic acid in acetonitrile, and methanol with a gradient elution. Detection was performed using Waters Xevo TQD. Result: This method was linear with a range of 25.1000 ng/mL for 6-MP and 6-TG, with consecutive r values of ≥0.996 and ≥0.995, respectively. The intra- and inter-day % difference value and coefficient of variation for the accuracy and precision were not more than 15% and 20%, respectively, at a concentration lower limit of quantitation. Conclusion: This method fulfilled the requirements of the European Medicines Agency guideline for validation.
Author supplied keywords
Cite
CITATION STYLE
Harahap, Y., Astrini, C. R., & Suryadi, H. (2018). Validation of 6-mercaptopurine and 6-thioguanine in dried blood spot by ultra performance liquid chromatography-tandem mass spectrometry. International Journal of Applied Pharmaceutics, 10(Special Issue 1), 412–415. https://doi.org/10.22159/ijap.2018.v10s1.91
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.